Bozeman Health Deaconness Cancer Center ( Site 1632) — Bozeman, Montana

Bozeman Health Deaconness Cancer Center ( Site 1632) is a clinical research site located in Bozeman, Montana, United States 59715.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Bozeman Health Deaconness Cancer Center ( Site 1632) has participated in 1 clinical trials.

Therapeutic areas: Metastatic Non-Small Cell Lung Cancer.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Bozeman Health Deaconness Cancer Center ( Site 1632)?

Bozeman Health Deaconness Cancer Center ( Site 1632) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Bozeman Health Deaconness Cancer Center ( Site 1632) conducted?

Bozeman Health Deaconness Cancer Center ( Site 1632) has 1 clinical trials on record. Their work covers Metastatic Non-Small Cell Lung Cancer.

Is Bozeman Health Deaconness Cancer Center ( Site 1632) accredited by Crixeo Health?

Bozeman Health Deaconness Cancer Center ( Site 1632) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Bozeman Health Deaconness Cancer Center ( Site 1632)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.